These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 292176)

  • 1. [Stimulation of body resistance in the therapy of perimaxillary phlegmons].
    Robustova TG; Shalumov AS
    Stomatologiia (Mosk); 1979; 58(5):36-41. PubMed ID: 292176
    [No Abstract]   [Full Text] [Related]  

  • 2. [Changes in the factors of nonspecific protection of the body during treatment of inflammatory diseases of the maxillofacial area in elderly persons using prodigiozan].
    Zakson ML; Bordonos VG
    Stomatologiia (Mosk); 1987; 66(6):9-11. PubMed ID: 3481503
    [No Abstract]   [Full Text] [Related]  

  • 3. [The physiological adaptation functions of cellular and humoral immunity in patients with phlegmons of the maxillofacial area].
    Iunuskhodzhaev E; Bazhanov NN; Belokrinitskiĭ DV; Shelepin AA
    Stomatologiia (Mosk); 1989; 68(2):23-7. PubMed ID: 2749813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Evaluation of the effectiveness of the combined treatment of perimaxillary phlegmons using hyperbaric oxygenation based on the body's nonspecific reactivity indices].
    Karapetian IS; Afanas'eva EA; Savchenko ZI; Kurakin AV
    Stomatologiia (Mosk); 1986; 65(5):33-5. PubMed ID: 3466424
    [No Abstract]   [Full Text] [Related]  

  • 5. [The use of gastric juice in the complex therapy of phlegmons of the perimaxillary region].
    Magarill ESh; Protasevich AI; Koltun RK; Krivolutskaia EG; Inkarbekov ZhB
    Stomatologiia (Mosk); 1972; 51(3):43-5. PubMed ID: 4506904
    [No Abstract]   [Full Text] [Related]  

  • 6. [Significance of a spiramycin-metronidazole combination in the treatment of acute, circumscribed perimaxillary cellulitis].
    Feki A
    Chir Dent Fr; 1981 Dec; 51(136):49-51. PubMed ID: 6948670
    [No Abstract]   [Full Text] [Related]  

  • 7. [Nonspecific resistance and inflammation in patients with odontogenic phlegmons of the maxillofacial area].
    Rogov KA; Brusina LI; Ter-Asaturov GP
    Arkh Patol; 1988; 50(7):38-45. PubMed ID: 3190480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Indications for the use of tactivin in the combined treatment of phlegmons of the maxillofacial area].
    Drobyshev VIu; Volozhin AI; Agapov VS; Sashkina TI
    Stomatologiia (Mosk); 1996; 75(4):27-30. PubMed ID: 8992659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Body reaction to microbial actions in phlegmons of the maxillofacial area].
    Iunuskhodzhaev E; Belokrinitskiĭ DV; Chikorin AK; Smirnova VM; Kochetov NN
    Stomatologiia (Mosk); 1985; 64(3):53-5. PubMed ID: 3863285
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinico-immunological parallels of nonspecific factors of body reactivity in patients with maxillofacial phlegmon].
    Bazhanov NN; Iunuskhodzhaev E; Belokrinitskiĭ DV; Smirnova VM; Kudriavitskiĭ AI
    Stomatologiia (Mosk); 1988; 67(1):32-5. PubMed ID: 3163192
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical use of thymalin in the prophylaxis and treatment of infectious-inflammatory diseases of the maxillofacial region].
    Solov'ev MM; Alekhova TM; Sysoeva EN; Morozov VG; Khavinson VKh
    Vestn Khir Im I I Grek; 1981 Dec; 127(12):6-11. PubMed ID: 7340043
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical and experimental bases for using dibasol in inflammatory diseases of the maxillofacial area].
    Alekhova TM
    Stomatologiia (Mosk); 1982; 61(1):15-7. PubMed ID: 6950550
    [No Abstract]   [Full Text] [Related]  

  • 13. [Nonspecific immunity indices and immunoglobulin levels in phlegmon of the maxillofacial area].
    Bordonos VG; Loganovskaia EN; Chernyshova LN
    Stomatologiia (Mosk); 1982; 61(1):47-9. PubMed ID: 6950564
    [No Abstract]   [Full Text] [Related]  

  • 14. [Dialysis of suppurative wounds in the overall treatment of perimaxillary phlegmons].
    Shalumov AZ; Robustova TG
    Stomatologiia (Mosk); 1979; 58(1):28-31. PubMed ID: 283583
    [No Abstract]   [Full Text] [Related]  

  • 15. [The efficacy of preparations with antioxidant action in the combined treatment of phlegmons of the maxillofacial area].
    Ragimov ChR
    Stomatologiia (Mosk); 1992; (3-6):35-7. PubMed ID: 1307152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Nonspecific reactivity in acute odontogenic infection].
    Khamitov FS; Faizov TT; Epshteĭn IaZ
    Stomatologiia (Mosk); 1983; 62(5):41-2. PubMed ID: 6579754
    [No Abstract]   [Full Text] [Related]  

  • 17. [Nonspecific body resistance in the acetylator phenotype of patients with odontogenic inflammatory processes in the maxillofacial area].
    Azimov M; Krakovskiĭ ME; Ashirmetov AKh
    Stomatologiia (Mosk); 1990; 69(6):33-5. PubMed ID: 2087715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Relationship of the indices of the T-, B- and A-immune systems of patients with phlegmons of the maxillofacial area].
    Robustova TG; Lebedev KA; Ushakov RV; Poniakina ID
    Stomatologiia (Mosk); 1985; 64(4):35-7. PubMed ID: 3876620
    [No Abstract]   [Full Text] [Related]  

  • 19. [Neutrophil-macrophage correlations during the healing of suppurative wounds in patients with phlegmons of the maxillofacial area undergoing combined treatment with the use of low-frequency ultrasound].
    Mukhsinov ME; Bazhanov NN; Pol'skiĭ VI
    Stomatologiia (Mosk); 1989; 68(5):45-9. PubMed ID: 2588280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prognostic importance of research on the immunoglobulin dynamics of patients with maxillofacial phlegmons].
    Bazhanov NN; Iunuskhodzhaev E; Belokrinitskiĭ DV; Kudriashova NM
    Stomatologiia (Mosk); 1985; 64(6):52-6. PubMed ID: 3866402
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.